OptimizeRx (OPRX) Short Interest Ratio & Short Volume → Trump’s last act as President (From Porter & Company) (Ad) Free OPRX Stock Alerts $10.42 +0.22 (+2.16%) (As of 05/1/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media OptimizeRx Short Interest DataCurrent Short Volume626,600 sharesPrevious Short Volume656,000 sharesChange Vs. Previous Month-4.48%Dollar Volume Sold Short$6.47 millionShort Interest Ratio / Days to Cover5.2Last Record DateApril 15, 2024Outstanding Shares18,180,000 sharesFloat Size15,970,000 sharesShort Percent of Float3.92%Today's Trading Volume177,497 sharesAverage Trading Volume129,059 sharesToday's Volume Vs. Average138% Short Selling OptimizeRx ? Sign up to receive the latest short interest report for OptimizeRx and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatOPRX Short Interest Over TimeOPRX Days to Cover Over TimeOPRX Percentage of Float Shorted Over Time Ad MillPub😱 This phenomenon is smashing regular market gainsThanks to a little-known “Pathfinder” trading phenomenon… Traders have recently unlocked one of the most powerful idea-generation sources in the history of trading. At every single market open.Click here to save your seat and join the next LIVE workshop! OptimizeRx Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/2024626,600 shares $6.47 million -4.5%3.9%5.2 $10.32 3/31/2024656,000 shares $7.97 million -13.1%4.1%5.5 $12.15 3/15/2024754,700 shares $9.58 million -3.3%4.7%6.4 $12.69 2/29/2024780,500 shares $12.36 million +0.3%4.9%5.6 $15.83 2/15/2024778,200 shares $12.38 million -0.1%4.9%5.5 $15.91 1/31/2024778,800 shares $11.00 million -19.6%4.9%4.8 $14.12 Get the Latest News and Ratings for OPRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for OptimizeRx and its competitors with MarketBeat's FREE daily newsletter. 1/15/2024968,400 shares $14.31 million +1.3%6.1%5.4 $14.78 12/31/2023956,300 shares $13.68 million -0.1%6.0%5.1 $14.31 12/15/2023957,200 shares $10.56 million -1.0%6.0%5.2 $11.03 11/30/2023967,100 shares $9.20 million +5.0%N/A6.1 $9.51 11/15/2023921,300 shares $8.88 million +5.7%N/A5.2 $9.64 10/31/2023871,400 shares $7.02 million +10.7%N/A4.5 $8.06 10/15/2023787,000 shares $6.68 million +7.6%5.0%4.7 $8.49 9/30/2023731,300 shares $5.69 million +8.1%4.6%5 $7.78 9/15/2023676,600 shares $5.66 million +8.3%4.2%4.7 $8.37 8/31/2023624,800 shares $5.32 million -11.2%3.9%4.6 $8.52 8/15/2023703,200 shares $6.39 million -4.3%4.4%5.6 $9.08 7/31/2023734,600 shares $10.25 million +2.8%4.5%6.9 $13.95 7/15/2023714,700 shares $10.53 million -3.1%4.3%6.3 $14.74 6/30/2023737,900 shares $10.54 million -10.9%4.5%6.1 $14.29 6/15/2023827,700 shares $12.43 million +14.6%5.1%6.2 $15.02 5/31/2023722,100 shares $10.14 million +1.6%4.4%3 $14.04 5/15/2023710,500 shares $9.29 million -19.7%4.3%2.8 $13.08 4/30/2023884,500 shares $13.29 million -3.7%5.4%3.6 $15.03 4/15/2023918,000 shares $13.23 million -14.2%5.6%3.7 $14.41 3/31/20231,070,000 shares $15.65 million -24.7%6.6%4.2 $14.63 3/15/20231,420,000 shares $18.37 million -4.7%8.7%5.6 $12.94 2/28/20231,490,000 shares $26.60 million -6.3%9.1%8.2 $17.85 2/15/20231,590,000 shares $29.03 million +3.3%9.7%11 $18.26 1/31/20231,540,000 shares $27.64 million +29.4%9.4%8.7 $17.95 1/15/20231,190,000 shares $22.04 million +3.5%7.3%6.5 $18.52 12/30/20221,150,000 shares $19.32 million +8.5%7.0%6.1 $16.80 12/15/20221,060,000 shares $18.56 million +3.9%6.5%5.4 $17.51 11/30/20221,020,000 shares $21.51 million -9.7%6.2%5.1 $21.09 11/15/20221,130,000 shares $24.91 million +2.7%6.9%5.4 $22.04 10/31/20221,100,000 shares $16.96 million +0.9%N/A4.2 $15.42 10/15/20221,090,000 shares $15.01 million +11.2%6.6%4.1 $13.77 9/30/2022980,000 shares $14.52 million -1.7%5.9%3.5 $14.82 9/15/2022996,800 shares $15.53 million +3.7%6.0%3.6 $15.58 8/31/2022961,500 shares $15.26 million -10.1%6.1%3.7 $15.87Protect Your Bank Account Before It’s Too Late (Ad)For months I’ve been warning about the federal government’s terrifying new program to control every American’s bank account. It gives them the power to monitor every single transaction …Stop right now and do these 3 things to protect yourself OPRX Short Interest - Frequently Asked Questions What is OptimizeRx's current short interest? Short interest is the volume of OptimizeRx shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 626,600 shares of OPRX short. 3.92% of OptimizeRx's shares are currently sold short. Learn More on OptimizeRx's current short interest. What is a good short interest ratio for OptimizeRx? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. OPRX shares currently have a short interest ratio of 5.0. Learn More on OptimizeRx's short interest ratio. Which institutional investors are shorting OptimizeRx? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of OptimizeRx: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for OptimizeRx? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.92% of OptimizeRx's floating shares are currently sold short. Is OptimizeRx's short interest increasing or decreasing? OptimizeRx saw a decrease in short interest in the month of April. As of April 15th, there was short interest totaling 626,600 shares, a decrease of 4.5% from the previous total of 656,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is OptimizeRx's float size? OptimizeRx currently has issued a total of 18,180,000 shares. Some of OptimizeRx's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. OptimizeRx currently has a public float of 15,970,000 shares. How does OptimizeRx's short interest compare to its competitors? 3.92% of OptimizeRx's shares are currently sold short. Here is how the short interest of companies compare to OptimizeRx: ZeroFox Holdings, Inc. (0.32%), Rimini Street, Inc. (8.44%), DHI Group, Inc. (3.41%), Steel Connect, Inc. (0.08%), Marchex, Inc. (0.33%), Edgio, Inc. (11.05%), Emerald Holding, Inc. (1.62%), Resources Connection, Inc. (6.35%), Zhihu Inc. (1.88%), Gravity Co., Ltd. (0.16%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short OptimizeRx stock? Short selling OPRX is an investing strategy that aims to generate trading profit from OptimizeRx as its price is falling. OPRX shares are trading up $0.22 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against OptimizeRx? A short squeeze for OptimizeRx occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of OPRX, which in turn drives the price of the stock up even further. How often is OptimizeRx's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including OPRX, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: ZFOX Short Squeeze RMNI Short Squeeze DHX Short Squeeze STCN Short Squeeze MCHX Short Squeeze EGIO Short Squeeze EEX Short Squeeze RGP Short Squeeze ZH Short Squeeze GRVY Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:OPRX) was last updated on 5/1/2024 by MarketBeat.com Staff From Our Partners😱 This phenomenon is smashing regular market gainsMillPubElon’s New Device is About to Shock the WorldInvestorPlaceDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsA.I. is a Tidal Wave - Here’s What to BuyChaikin AnalyticsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingPOTUS in ‘25 Not Biden/Trump, ButThe Freeport SocietyAI “wealth window” is closing June 25thParadigm Press4 coins to be the “Next Bitcoin”True Market Insiders